Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

JENBURKT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.005.966.836.735.38

What is the latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS is 9.00 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20259.00
Mar20245.96
Mar20236.83
Mar20226.73
Mar20215.38

How is EV/Core EBITDA of JENBURKT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 9
51.01
Mar2024 5.96
-12.74
Mar2023 6.83
1.49
Mar2022 6.73
25.09
Mar2021 5.38 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹464.2 Cr 4.1% 5.5% 1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹98,892.8 Cr 2.6% -7.4% -16.3% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

4.1%

5.5%

1.9%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses